Mostrando 10 resultados de: 22
Filtros aplicados
Publisher
Biotecnologia Aplicada(5)
Bionatura(4)
Electronic Journal of Biotechnology(2)
Molecular Immunology(2)
Biomaterials Science(1)
Área temáticas
Farmacología y terapéutica(11)
Microorganismos, hongos y algas(10)
Fisiología humana(5)
Bioquímica(4)
Medicina y salud(3)
Área de conocimiento
Inmunología(7)
Biotecnología(5)
Enfermedad cardiovascular(4)
Bioquímica(3)
Cáncer(2)
Bacteriophages as natural antibiotics
OtherAbstract:Palabras claves:Autores:Santiago Nelson VispoFuentes:scopusBiomedical science to tackle the COVID-19 pandemic: Current status and future perspectives
ReviewAbstract: The coronavirus infectious disease (COVID-19) pandemic emerged at the end of 2019, and was caused byPalabras claves:clinical trials, DIAGNOSTICS, Nanomedicine, prevention, Treatment, vaccinesAutores:Camilo Zamora-Ledezma, David F.C. Clavijo, Ernesto Medina Dagger, Federico L. Sinche, Frank Alexis, Santiago Nelson Vispo, Si Amar DahoumaneFuentes:googlescopusAntitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)
ArticleAbstract: Protein Kinase (casein kinase 2, CK2) is a serine-threonine kinase that is frequently dysregulated iPalabras claves:Autores:Acevedo B.E., Alonso D.F., Falcón-Cama V., López-Mola E., Mendoza O., Perea-Rodríguez S.E., Puchades Y., Reyes O., Santiago Nelson Vispo, Santos-Savio A., Silva R., Torrens I.Fuentes:scopusA monoclonal antibody against NeuGc-containing gangliosides contains a regulatory idiotope involved in the interaction with B and T cells
ArticleAbstract: P3 (IgM-κ) is a monoclonal antibody (mAb) reacting with N-glycolyl neuraminic acid (NeuGc)-containinPalabras claves:H-CDR3, Idiotype, Monoclonal antibody, N-Glycolyl neuraminic acidAutores:Mier E., Perez A., Rodríguez R., Santiago Nelson Vispo, Vázquez A.M.Fuentes:scopusCancer therapies
OtherAbstract:Palabras claves:Autores:Santiago Nelson VispoFuentes:scopusCellulose-based hydrogels towards an antibacterial wound dressing
ArticleAbstract: Hydrogels are promising candidates for wound healing bandages because they can mimic the native skinPalabras claves:Autores:Camilo Zamora-Ledezma, Dario Niebieskikwiat, Esteban Guamba, Frank Alexis, Santiago Nelson Vispo, Santos-Oliveira R., Singh A.K., Whitehead D.C.Fuentes:scopusApplication of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier
ReviewAbstract: The main obstacle to biopharmaceutical delivery in therapeutic concentration into the brain for treaPalabras claves:blood-brain barrier, drug delivery, molecular trojan horse, Phage display technology, receptor-mediated transcytosis, shuttle peptidesAutores:Ramos O.S., Santiago Nelson Vispo, Suárez V.M.Fuentes:scopusGangliosides, Ab1 and Ab2 antibodies. I. Towards a molecular dissection of an idiotype-anti-idiotype system
ArticleAbstract: This report is focused on the molecular basis for the interaction of a monoclonal antibody (mAb) andPalabras claves:Anti-idiotypic antibodies, H-CDR, N-Glycolyl-gangliosidesAutores:González M., López-Requena A., Mateo de Acosta C., Moreno E., Pérez R., Puchades Y., Santiago Nelson Vispo, Talavera A., Vázquez A.M.Fuentes:scopusGene therapy using a plasmid that expresses the VEGF<inf>121</inf> for the treatment of the critical ischemic cardiophaty
ArticleAbstract: Here we report, for the first time in Cuba, the use of gene therapy to evaluate the positive therapePalabras claves:Clinical study, Gene therapy, Vascular endothelial growth factorAutores:Batista J.F., Betancourt B.Y., Chaos N., Chil R., Coca M., Fleites G., García A., García E., Garzón E., González M.J., González N., González R., Guevara L., Guillén-Nieto G.E., Méndez T., Milán R., Naffe M., Quián Y.P., Reina C., Santiago Nelson Vispo, Senra G., Seralena A., Suárez L.R., Vazquez R., Villar A.Fuentes:scopusGene therapy with a plasmid expressing the VEGF<inf>121</inf> for the treatment of critical ischemic cardiopathy
ArticleAbstract: Here we report, for the first time in Cuba, the evaluation of the positive therapeutic action and saPalabras claves:Autores:Batista J.F., Betancourt B.Y., Chaos N., Chil R., Coca M., Fleites G., García A., García E., Garzón E., González M.J., González N., González R., Guevara L., Guillén-Nieto G.E., Méndez T., Milán R., Naffe M., Quián Y.P., Reina C., Santiago Nelson Vispo, Senra G., Seralena A., Suárez L.R., Vazquez R., Villar A.Fuentes:scopus